{"pmid":32307313,"title":"[Practical update of total dose compensation in case of temporary interruption of external radiotherapy in the COVID-19 pandemic context].","text":["[Practical update of total dose compensation in case of temporary interruption of external radiotherapy in the COVID-19 pandemic context].","Overall treatment time is an important factor of local recurrence and indirectly of distant evolution, namely in case of protracted treatments. The current pandemic impacts on the duration of radiotherapy if patients under treatments and synchronously suffering from COVID-19. The models used to compensate the total dose in case of temporary treatment interruption are well known but it is of importance in that pandemic context to update and homogenize clinical practice in order to improve local control without increasing normal tissue complications.","Cancer Radiother","Azria, D","Hennequin, C","Giraud, P","32307313"],"abstract":["Overall treatment time is an important factor of local recurrence and indirectly of distant evolution, namely in case of protracted treatments. The current pandemic impacts on the duration of radiotherapy if patients under treatments and synchronously suffering from COVID-19. The models used to compensate the total dose in case of temporary treatment interruption are well known but it is of importance in that pandemic context to update and homogenize clinical practice in order to improve local control without increasing normal tissue complications."],"journal":"Cancer Radiother","authors":["Azria, D","Hennequin, C","Giraud, P"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32307313","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.canrad.2020.04.001","keywords":["compensation","dose totale","radiotherapy","radiotherapie","total dose","treatment duration","etalement"],"source":"PubMed","weight":0,"_version_":1664632501523447809,"score":8.518259,"similar":[{"pmid":32334905,"title":"[Management of a radiotherapy center during the COVID-19 outbreak: The experience of the Mulhouse hospital centre (France)].","text":["[Management of a radiotherapy center during the COVID-19 outbreak: The experience of the Mulhouse hospital centre (France)].","The COVID-19 outbreak grows exponentially in our country. Despite most of patients develops benign symptoms, cancer patients are at risk of a severe form of the disease. Radiotherapy centres are a potential contamination place due to the number of patients treated and staff present. Their organization during the outbreak period aims to ensure continuity of care while limiting the risk of death from COVID-19. In the radiotherapy department of Mulhouse hospital (France), we pointed five points out: protection of medical and paramedical staff, protection of patients undergoing treatment, detection of patients suspected of being infected by SARS-CoV-2 and their management, reorganization of the patient circuit and measures regarding the quality management. This reflection, which began at the beginning of the outbreak in our city, allows us to preserve the access to radiotherapy treatments by anticipating the risk of spreading the virus. Through biweekly meetings, we continue to adapt to the epidemic in our department, considering our material resources. The ability to perform diagnostic tests in all suspect patients would also allow us to refine our procedures.","Cancer Radiother","Ohnleiter, T","Piot, L","Rogenmuser, A","Noirclerc, M","Hamlaoui, R","Grandgirard, A","32334905"],"abstract":["The COVID-19 outbreak grows exponentially in our country. Despite most of patients develops benign symptoms, cancer patients are at risk of a severe form of the disease. Radiotherapy centres are a potential contamination place due to the number of patients treated and staff present. Their organization during the outbreak period aims to ensure continuity of care while limiting the risk of death from COVID-19. In the radiotherapy department of Mulhouse hospital (France), we pointed five points out: protection of medical and paramedical staff, protection of patients undergoing treatment, detection of patients suspected of being infected by SARS-CoV-2 and their management, reorganization of the patient circuit and measures regarding the quality management. This reflection, which began at the beginning of the outbreak in our city, allows us to preserve the access to radiotherapy treatments by anticipating the risk of spreading the virus. Through biweekly meetings, we continue to adapt to the epidemic in our department, considering our material resources. The ability to perform diagnostic tests in all suspect patients would also allow us to refine our procedures."],"journal":"Cancer Radiother","authors":["Ohnleiter, T","Piot, L","Rogenmuser, A","Noirclerc, M","Hamlaoui, R","Grandgirard, A"],"date":"2020-04-27T11:00:00Z","year":2020,"_id":"32334905","week":"202018|Apr 27 - May 03","doi":"10.1016/j.canrad.2020.04.002","keywords":["covid-19","department","epidemic","organisation","organization","patient","radiotherapy","radiotherapie","service","epidemie"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["France","France"],"countries":["France"],"countries_codes":["FRA|France"],"_version_":1665172301956513792,"score":226.19456},{"pmid":32292839,"pmcid":"PMC7118610","title":"Prostate Cancer Radiotherapy Recommendations in Response to COVID-19.","text":["Prostate Cancer Radiotherapy Recommendations in Response to COVID-19.","Purpose: During a global pandemic the benefit of routine visits and treatment of cancer patients must be weighed against the risks to patients, staff, and society. Prostate cancer is one of the most common cancers Radiation Oncology departments treat, and efficient resource utilization is essential in the setting of a pandemic. Herein, we aim to establish recommendations and a framework by which to evaluate prostate radiotherapy management decisions. Patients and Methods: Radiation Oncologists from the United States and United Kingdom rapidly conducted a systematic review and agreed upon recommendations to safely manage prostate cancer patients during the COVID-19 pandemic. A RADS framework was created: Remote visits, and Avoidance, Deferment, and Shortening of radiotherapy was applied to determine appropriate approaches. Results: Recommendations are provided by National Comprehensive Cancer Network (NCCN) risk group, including clinical node positive, post-prostatectomy, oligometastatic, and low volume M1 disease. Across all prostate cancer stages, telemedicine consultations and return visits were recommended when resources/staff available. Delays in consultations and return visits was deemed safe based on stage of disease between 1-6 months. Treatment can be avoided or delayed until safe for very low, low, and favorable intermediate-risk disease. Unfavorable intermediate-risk, high-risk, clinical node positive, recurrence post-surgery, oligometastatic, and low-volume M1 disease can receive neoadjuvant hormone therapy for 4-6 months as necessary. Ultrahypofractionation was preferred for localized, oligometastatic, and low volume M1, and moderate hypofractionation was preferred for post-prostatectomy and clinical node positive disease. Salvage was preferred to adjuvant radiation. Conclusion: Resources can be reduced for all identified stages of prostate cancer. The RADS (Remote visits, and Avoidance, Deferment, and Shortening of radiotherapy) framework can be applied to other disease sites to help with decision making in a global pandemic.","Adv Radiat Oncol","Zaorsky, Nicholas G","Yu, James B","McBride, Sean M","Dess, Robert T","Jackson, William C","Mahal, Brandon A","Chen, Ronald","Choudhury, Ananya","Henry, Ann","Syndikus, Isabel","Mitin, Timur","Tree, Alison","Kishan, Amar U","Spratt, Daniel E","32292839"],"abstract":["Purpose: During a global pandemic the benefit of routine visits and treatment of cancer patients must be weighed against the risks to patients, staff, and society. Prostate cancer is one of the most common cancers Radiation Oncology departments treat, and efficient resource utilization is essential in the setting of a pandemic. Herein, we aim to establish recommendations and a framework by which to evaluate prostate radiotherapy management decisions. Patients and Methods: Radiation Oncologists from the United States and United Kingdom rapidly conducted a systematic review and agreed upon recommendations to safely manage prostate cancer patients during the COVID-19 pandemic. A RADS framework was created: Remote visits, and Avoidance, Deferment, and Shortening of radiotherapy was applied to determine appropriate approaches. Results: Recommendations are provided by National Comprehensive Cancer Network (NCCN) risk group, including clinical node positive, post-prostatectomy, oligometastatic, and low volume M1 disease. Across all prostate cancer stages, telemedicine consultations and return visits were recommended when resources/staff available. Delays in consultations and return visits was deemed safe based on stage of disease between 1-6 months. Treatment can be avoided or delayed until safe for very low, low, and favorable intermediate-risk disease. Unfavorable intermediate-risk, high-risk, clinical node positive, recurrence post-surgery, oligometastatic, and low-volume M1 disease can receive neoadjuvant hormone therapy for 4-6 months as necessary. Ultrahypofractionation was preferred for localized, oligometastatic, and low volume M1, and moderate hypofractionation was preferred for post-prostatectomy and clinical node positive disease. Salvage was preferred to adjuvant radiation. Conclusion: Resources can be reduced for all identified stages of prostate cancer. The RADS (Remote visits, and Avoidance, Deferment, and Shortening of radiotherapy) framework can be applied to other disease sites to help with decision making in a global pandemic."],"journal":"Adv Radiat Oncol","authors":["Zaorsky, Nicholas G","Yu, James B","McBride, Sean M","Dess, Robert T","Jackson, William C","Mahal, Brandon A","Chen, Ronald","Choudhury, Ananya","Henry, Ann","Syndikus, Isabel","Mitin, Timur","Tree, Alison","Kishan, Amar U","Spratt, Daniel E"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32292839","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.adro.2020.03.010","keywords":["coronavirus","prostate cancer","radiation oncology","radiotherapy"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["United States","United Kingdom"],"countries":["United States","United Kingdom"],"countries_codes":["USA|United States","GBR|United Kingdom"],"_version_":1664636192777306112,"score":202.25652},{"pmid":32271627,"title":"Self-Isolation Compliance In The COVID-19 Era Influenced By Compensation: Findings From A Recent Survey In Israel.","text":["Self-Isolation Compliance In The COVID-19 Era Influenced By Compensation: Findings From A Recent Survey In Israel.","A new Coronavirus disease (COVID-19) outbreak is spreading since December 2019. In an attempt to contain the disease, health authorities call for self-quarantine of individuals suspected as exposures. Health officials assume the public will comply in high rates; however, studies suggest that a major obstacle to compliance for household quarantine is concern over loss of income. A cross sectional study of the adult population of Israel was conducted in the last week of February 2020 to assess public attitudes toward the COVID-19 outbreak. In particular, public compliance rates with self-quarantine were assessed depending on compensation for lost wages. The results suggest that when compensation was assumed, the compliance rate was 94%; yet, when compensation was removed, the compliance rate dropped to less than 57%. This study demonstrates that providing people with assurances for their livelihood during self-quarantine is an important component in compliance with public health regulations. [Editor's Note: This fast-track Ahead-of-Print article is the accepted version of the peer-reviewed manuscript. The final edited version will appear in an upcoming issue of Health Affairs.].","Health Aff (Millwood)","Bodas, Moran","Peleg, Kobi","32271627"],"abstract":["A new Coronavirus disease (COVID-19) outbreak is spreading since December 2019. In an attempt to contain the disease, health authorities call for self-quarantine of individuals suspected as exposures. Health officials assume the public will comply in high rates; however, studies suggest that a major obstacle to compliance for household quarantine is concern over loss of income. A cross sectional study of the adult population of Israel was conducted in the last week of February 2020 to assess public attitudes toward the COVID-19 outbreak. In particular, public compliance rates with self-quarantine were assessed depending on compensation for lost wages. The results suggest that when compensation was assumed, the compliance rate was 94%; yet, when compensation was removed, the compliance rate dropped to less than 57%. This study demonstrates that providing people with assurances for their livelihood during self-quarantine is an important component in compliance with public health regulations. [Editor's Note: This fast-track Ahead-of-Print article is the accepted version of the peer-reviewed manuscript. The final edited version will appear in an upcoming issue of Health Affairs.]."],"journal":"Health Aff (Millwood)","authors":["Bodas, Moran","Peleg, Kobi"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32271627","week":"202015|Apr 06 - Apr 12","doi":"10.1377/hlthaff.2020.00382","keywords":["covid-19","compensation","compliance","coronavirus","decision making","diseases","emergency medicine","epidemiology","global health","public health","quarantine","regulation","self-quarantine","health policy"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["Israel","Israel"],"countries":["Israel"],"countries_codes":["ISR|Israel"],"_version_":1664637315683713025,"score":185.90843},{"pmid":32302681,"title":"Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: an ASTRO-ESTRO consensus statement.","text":["Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: an ASTRO-ESTRO consensus statement.","INTRODUCTION: Due to the unprecedented disruption of health care services by the COVID-19 pandemic, the American Society of Radiation Oncology (ASTRO) and the European Society for Radiotherapy and Oncology (ESTRO) identified an urgent need to issue practice recommendations for radiation oncologists treating head and neck cancer (HNC), in a time of heightened risk for patients and staff, and of limited resources. METHODS: A panel of international experts from ASTRO, ESTRO and select Asia-Pacific countries completed a modified rapid Delphi process. Questions and topics were presented to the group, and subsequent questions developed from iterative feedback. Each survey was open online for 24 hours, and successive rounds started within 24 hours of the previous round. The chosen cutoffs for strong agreement (>/=80%) and agreement (>/=66%) were extrapolated from the RAND methodology. Two pandemic scenarios: early (risk mitigation) and late (severely reduced radiotherapy resources) were evaluated. The panel developed treatment recommendations for five HNC cases. RESULTS: In total, 29/31 (94%) of those invited accepted, and after a replacement 30/30 completed all three surveys (100% response rate). There was agreement or strong agreement across a number of practice areas including: treatment prioritisation, whether to delay initiation or interrupt radiotherapy for intercurrent SARS-CoV-2 infection, approaches to treatment (radiation dose-fractionation schedules and use of chemotherapy in each pandemic scenario), management of surgical cases in event of operating room closures, and recommended adjustments to outpatient clinic appointments and supportive care. CONCLUSIONS: This urgent practice recommendation was issued in the knowledge of the very difficult circumstances in which our patients find themselves at present, navigating strained health care systems functioning with limited resources and at heightened risk to their health during the COVID-19 pandemic. The aim of this consensus statement is to ensure high-quality HNC treatments continue, to save lives and for symptomatic benefit.","Int J Radiat Oncol Biol Phys","Thomson, David J","Palma, David","Guckenberger, Matthias","Balermpas, Panagiotis","Beitler, Jonathan J","Blanchard, Pierre","Brizel, David","Budach, Wilfred","Caudell, Jimmy","Corry, June","Corvo, Renzo","Evans, Mererid","Garden, Adam S","Giralt, Jordi","Gregoire, Vincent","Harari, Paul M","Harrington, Kevin","Hitchcock, Ying J","Johansen, Jorgen","Kaanders, Johannes","Koyfman, Shlomo","Langendijk, J A","Le, Quynh-Thu","Lee, Nancy","Margalit, Danielle","Mierzwa, Michelle","Porceddu, Sandro","Soong, Yoke Lim","Sun, Ying","Thariat, Juliette","Waldron, John","Yom, Sue S","32302681"],"abstract":["INTRODUCTION: Due to the unprecedented disruption of health care services by the COVID-19 pandemic, the American Society of Radiation Oncology (ASTRO) and the European Society for Radiotherapy and Oncology (ESTRO) identified an urgent need to issue practice recommendations for radiation oncologists treating head and neck cancer (HNC), in a time of heightened risk for patients and staff, and of limited resources. METHODS: A panel of international experts from ASTRO, ESTRO and select Asia-Pacific countries completed a modified rapid Delphi process. Questions and topics were presented to the group, and subsequent questions developed from iterative feedback. Each survey was open online for 24 hours, and successive rounds started within 24 hours of the previous round. The chosen cutoffs for strong agreement (>/=80%) and agreement (>/=66%) were extrapolated from the RAND methodology. Two pandemic scenarios: early (risk mitigation) and late (severely reduced radiotherapy resources) were evaluated. The panel developed treatment recommendations for five HNC cases. RESULTS: In total, 29/31 (94%) of those invited accepted, and after a replacement 30/30 completed all three surveys (100% response rate). There was agreement or strong agreement across a number of practice areas including: treatment prioritisation, whether to delay initiation or interrupt radiotherapy for intercurrent SARS-CoV-2 infection, approaches to treatment (radiation dose-fractionation schedules and use of chemotherapy in each pandemic scenario), management of surgical cases in event of operating room closures, and recommended adjustments to outpatient clinic appointments and supportive care. CONCLUSIONS: This urgent practice recommendation was issued in the knowledge of the very difficult circumstances in which our patients find themselves at present, navigating strained health care systems functioning with limited resources and at heightened risk to their health during the COVID-19 pandemic. The aim of this consensus statement is to ensure high-quality HNC treatments continue, to save lives and for symptomatic benefit."],"journal":"Int J Radiat Oncol Biol Phys","authors":["Thomson, David J","Palma, David","Guckenberger, Matthias","Balermpas, Panagiotis","Beitler, Jonathan J","Blanchard, Pierre","Brizel, David","Budach, Wilfred","Caudell, Jimmy","Corry, June","Corvo, Renzo","Evans, Mererid","Garden, Adam S","Giralt, Jordi","Gregoire, Vincent","Harari, Paul M","Harrington, Kevin","Hitchcock, Ying J","Johansen, Jorgen","Kaanders, Johannes","Koyfman, Shlomo","Langendijk, J A","Le, Quynh-Thu","Lee, Nancy","Margalit, Danielle","Mierzwa, Michelle","Porceddu, Sandro","Soong, Yoke Lim","Sun, Ying","Thariat, Juliette","Waldron, John","Yom, Sue S"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32302681","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.ijrobp.2020.04.016","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664635401412804608,"score":168.23398},{"pmid":32322758,"pmcid":"PMC7175910","title":"Management of Locally Advanced Rectal Cancer During The COVID-19 Pandemic: A Necessary Paradigm Change at Memorial Sloan Kettering Cancer Center.","text":["Management of Locally Advanced Rectal Cancer During The COVID-19 Pandemic: A Necessary Paradigm Change at Memorial Sloan Kettering Cancer Center.","The COVID-19 pandemic will consume significant health care resources. Given concerns for rapidly rising infection rates in the US, impending staffing shortages, and potential for resource re-allocation, we rapidly re-evaluated our rectal cancer practice polices during this public health emergency. Previous to the pandemic we commonly utilized total neoadjuvant therapy (TNT) with a strong preference for long course chemoradiation (LCCRT). In the setting of the ongoing pandemic we now mandate short course radiation therapy (SCRT). Despite multiple randomized trials demonstrating no difference in locoregional recurrence, distant recurrence, or overall survival between SCRT and LRCCT, adaptation of SCRT in the United States has been low given concerns for less tumor downstaging and increased toxicity. In the setting of the ongoing and likely prolonged COVID-19 pandemic, we feel that these concerns must be re-evaluated, as SCRT presents a well-validated alternative that will allow us to meet the needs of a greater number of potentially curable patients, at a time when our resources are severely and acutely constrained.","Adv Radiat Oncol","Romesser, Paul B","Wu, Abraham J","Cercek, Andrea","Smith, J Joshua","Weiser, Martin","Saltz, Leonard","Garcia-Aguilar, Julio","Crane, Christopher H","32322758"],"abstract":["The COVID-19 pandemic will consume significant health care resources. Given concerns for rapidly rising infection rates in the US, impending staffing shortages, and potential for resource re-allocation, we rapidly re-evaluated our rectal cancer practice polices during this public health emergency. Previous to the pandemic we commonly utilized total neoadjuvant therapy (TNT) with a strong preference for long course chemoradiation (LCCRT). In the setting of the ongoing pandemic we now mandate short course radiation therapy (SCRT). Despite multiple randomized trials demonstrating no difference in locoregional recurrence, distant recurrence, or overall survival between SCRT and LRCCT, adaptation of SCRT in the United States has been low given concerns for less tumor downstaging and increased toxicity. In the setting of the ongoing and likely prolonged COVID-19 pandemic, we feel that these concerns must be re-evaluated, as SCRT presents a well-validated alternative that will allow us to meet the needs of a greater number of potentially curable patients, at a time when our resources are severely and acutely constrained."],"journal":"Adv Radiat Oncol","authors":["Romesser, Paul B","Wu, Abraham J","Cercek, Andrea","Smith, J Joshua","Weiser, Martin","Saltz, Leonard","Garcia-Aguilar, Julio","Crane, Christopher H"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32322758","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.adro.2020.04.011","source":"PubMed","topics":["Prevention"],"weight":1,"locations":["US","United States"],"countries":["United States"],"countries_codes":["USA|United States"],"_version_":1664895932845522944,"score":147.08304}]}